| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.5 |